↓ Skip to main content

Cochrane Database of Systematic Reviews

Trastuzumab containing regimens for early breast cancer

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
13 news outlets
blogs
2 blogs
policy
2 policy sources
twitter
56 X users
patent
2 patents
facebook
3 Facebook pages
wikipedia
1 Wikipedia page
googleplus
1 Google+ user

Citations

dimensions_citation
545 Dimensions

Readers on

mendeley
536 Mendeley
Title
Trastuzumab containing regimens for early breast cancer
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd006243.pub2
Pubmed ID
Authors

Lorenzo Moja, Ludovica Tagliabue, Sara Balduzzi, Elena Parmelli, Vanna Pistotti, Valentina Guarneri, Roberto D'Amico

Abstract

Approximately one-fifth of women who develop early breast cancer have HER2-positive tumours, which if untreated, have a worse prognosis than HER2-negative tumours. Trastuzumab is a selective treatment targeting the HER2 pathway. Although the results on efficacy seem to support its use, there are potential cardiac toxicities which need to be considered, especially for women at lower risk of recurrence, or those at increased cardiovascular risk.

X Demographics

X Demographics

The data shown below were collected from the profiles of 56 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 536 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 3 <1%
Canada 3 <1%
Korea, Republic of 2 <1%
United States 2 <1%
Chile 1 <1%
United Kingdom 1 <1%
Austria 1 <1%
Greece 1 <1%
Brazil 1 <1%
Other 0 0%
Unknown 521 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 59 11%
Researcher 57 11%
Student > Master 57 11%
Student > Ph. D. Student 48 9%
Student > Postgraduate 46 9%
Other 94 18%
Unknown 175 33%
Readers by discipline Count As %
Medicine and Dentistry 209 39%
Agricultural and Biological Sciences 27 5%
Biochemistry, Genetics and Molecular Biology 26 5%
Pharmacology, Toxicology and Pharmaceutical Science 22 4%
Nursing and Health Professions 19 4%
Other 46 9%
Unknown 187 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 160. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2024.
All research outputs
#269,526
of 26,317,969 outputs
Outputs from Cochrane database of systematic reviews
#432
of 13,209 outputs
Outputs of similar age
#1,089
of 176,114 outputs
Outputs of similar age from Cochrane database of systematic reviews
#4
of 185 outputs
Altmetric has tracked 26,317,969 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,209 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 176,114 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 185 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.